ASCP Fall Meeting

Fall Psychopharmacology Update: State-of-the-Art Meeting

 October 21-22, 2017

The Roosevelt Hotel New York

 

2017 Topics and Presenters Include:

  • Ketamine, Jerry Sanacora, M.D., Ph.D.
  • Suicide Risk Assessment, Safety Planning, Pharmacological and Psychosocial Interventions, Mark Olfson, M.D., M.P.H.
  • Psychotropic Drug Adherence, Martha Sajatovic, M.D.
  • Medical Malpractice and Clinical Pharmacology, Sheldon Preskorn, M.D.
  • Pharmacogenetics and the Prediction and Reduction of Adverse Affects, Rajnish Mago, M.D.
  • Treatment Resistant Depression, Michael Thase, M.D.
  • Inflammation and Depression, Mark Rapaport, M.D.
  • Forensics in Postpartum Illness, Margaret Spinelli, M.D.
  • Use of Atypicals in Nonpsychotic Populations, Joseph Goldberg, M.D.
  • Metabolic Effects of Psychotropics, John Newcomer, M.D.
  • Sexual Dysfunction, Anita Clayton, M.D.
  • Schizophrenia, Don Goff, M.D.

CME Credit:

The American Society of Clinical Psychopharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Clinical Psychopharmacology takes responsibility for the content, quality, and scientific integrity of this CME Activity. In 2017, the Society designates this live meeting for a maximum of 15 AMA PRA Category 1 Credit(s)™. Each physician should claim only those hours of credit that (s) he actually spent in the educational activity.

 

Past Meetings:

2016: Grand Hyatt New York, October 29-30, 2016.

2015: Grand Hyatt New York, October 4-5, 2015.

2014: Grant Hyatt New York, October 11-2, 2014.